Cerity Partners LLC Biomarin Pharmaceutical Inc Transaction History

Cerity Partners LLC

$37.7 Billion
Q2 2024

A detailed history of Cerity Partners LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Cerity Partners LLC holds 7,628 shares of BMRN stock, worth $538,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,628

Previous 6,994 9.06%

Holding current value

$538,384

Previous $610,000 2.95%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $47,188 - $58,467	634 Added 9.06%	7,628 $628,000
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $326,104 - $385,209	3,891 Added 125.39%	6,994 $610,000
Q4 2023 Jan 26, 2024	BUY	$76.22 - $98.51 $236,510 - $305,676	3,103 New	3,103 $299,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $18,636 - $21,564	215 Added 5.78%	3,935 $341,000
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $34,130 - $45,618	389 Added 11.68%	3,720 $361,000
Q4 2022 Feb 15, 2023	BUY	$80.93 - $108.63 $38,846 - $52,142	480 Added 16.84%	3,331 $344,000
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $36,561 - $43,138	-445 Reduced 13.5%	2,851 $242,000
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $235,598 - $286,257	3,296 New	3,296 $273,000
Q1 2022 Apr 25, 2022	SELL	$74.28 - $92.69 $170,918 - $213,279	-2,301 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $165,027 - $210,472	2,301 New	2,301 $205,000
Q3 2019 Oct 30, 2019	SELL	$67.4 - $85.11 $164,388 - $207,583	-2,439 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1,285 - $1,502	16 Added 0.66%	2,439 $209,000
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $13,303 - $15,581	-158 Reduced 6.12%	2,423 $215,000
Q4 2018 Feb 06, 2019	BUY	$80.14 - $106.07 $8,254 - $10,925	103 Added 4.16%	2,581 $220,000
Q3 2018 Nov 15, 2018	SELL	$93.92 - $105.72 $3,568 - $4,017	-38 Reduced 1.51%	2,478 $240,000
Q2 2018 Aug 15, 2018	SELL	$76.01 - $99.03 $154,680 - $201,526	-2,035 Reduced 44.72%	2,516 $237,000
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $353,476 - $421,559	4,551 New	4,551 $369,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $392,897 - $462,807	-4,865 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $392,119 - $461,931	4,865	4,865 $453,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Biomarin Pharmaceutical Inc Transaction History